Subhas Gokulakkrishna, Shah Asha J, Gupta Aditya, Cook Jonathan, Dubay Linda, Silapaswan Sumet, Kolachalam Ramachandra, Kestenberg William, Ferguson Lorenzo, Jacobs Michael J, Goriel Yousif, Mittal Vijay K
Department of Surgery, Providence Hospital and Medical Centers, Southfield, Michigan 48075, USA.
Int Surg. 2011 Jan-Mar;96(1):18-20. doi: 10.9738/1340.1.
The trend in breast surgery has shifted toward breast conservation. We reviewed our third and fourth breast re-excision cases, with an analysis of various factors used in making this decision. A retrospective analysis identified 585 patients who underwent re-excision surgery for positive or close margins of invasive carcinoma or ductal carcinoma in situ (DCIS). Of these patients 75 (13%) and 17 (3%) underwent third and fourth re-excisions, respectively. The indication for a third re-excision was the presence of positive and/or close (< or = 1 mm) margins for invasive carcinoma or DCIS in 72/75 patients. A third re-excision was done 31 days (range 8-123 days) after the second re-excision. Re-excision of margins was done in 45 (60%) patients, whereas 30 (40%) patients underwent mastectomy. Residual tumor mandated a fourth re-excision in 17 patients, which was done 45 days (range 14-87 days) after the third surgery. Re-excision of margins was done in 6 patients, whereas 11 patients underwent mastectomy. Involved or close margins with DCIS were the most common indication for re-excision, accounting for 61/75 (82%) of third and 16/17 (94%) of fourth re-excisions. Histopathology revealed that 28/75 (37%) of third and 7/17 (41%) of fourth re-excision patients had no residual tumor. In conclusion, the majority of re-excisions was done for margins < 1 mm. Lower rates of re-excision were noted in well-differentiated invasive carcinomas. A close or involved DCIS margin was more likely to lead to a third and even a fourth re-excision. The absence of residual tumors in 40% of patients undergoing third and fourth re-excisions calls for a review of margin guidelines for breast re-excision.
乳腺手术的趋势已转向保乳治疗。我们回顾了第三和第四例乳腺再次切除病例,并分析了做出该决定时所考虑的各种因素。一项回顾性分析确定了585例因浸润性癌或导管原位癌(DCIS)切缘阳性或切缘接近而接受再次切除手术的患者。在这些患者中,分别有75例(13%)和17例(3%)接受了第三次和第四次再次切除。第三次再次切除的指征是72/75例患者存在浸润性癌或DCIS的阳性和/或切缘接近(≤1mm)。第三次再次切除在第二次再次切除后31天(范围8 - 123天)进行。45例(60%)患者进行了切缘再次切除,而30例(40%)患者接受了乳房切除术。17例患者因残留肿瘤需要进行第四次再次切除,这在第三次手术后45天(范围14 - 87天)进行。6例患者进行了切缘再次切除,而11例患者接受了乳房切除术。DCIS累及或切缘接近是再次切除最常见的指征,占第三次再次切除的61/75(82%)和第四次再次切除的16/17(94%)。组织病理学显示,第三次再次切除患者中有28/75(37%)和第四次再次切除患者中有7/17(41%)无残留肿瘤。总之,大多数再次切除是因为切缘<1mm。高分化浸润性癌的再次切除率较低。DCIS切缘接近或累及更有可能导致第三次甚至第四次再次切除。40%接受第三次和第四次再次切除的患者无残留肿瘤,这需要重新审视乳腺再次切除的切缘指导原则。